Professional Documents
Culture Documents
Emerg Med J: first published as 10.1136/emermed-2021-211306.3 on 19 March 2021. Downloaded from http://emj.bmj.com/ on August 22, 2022 at Universidad de Chile 2224 Medicina
Norte. Protected by copyright.
Emerg Med J: first published as 10.1136/emermed-2021-211306.3 on 19 March 2021. Downloaded from http://emj.bmj.com/ on August 22, 2022 at Universidad de Chile 2224 Medicina
Three-part question 8. CINAHL (5 OR 6 OR 7) 2431 23. Medline (post circumcision* bleed*).
In patients with postcircumcision bleeding, 9. CINAHL (4 AND 8) 0 ti,ab 47
does topical tranexamic acid (TXA) reduce 10. EMBASE (topical tranexamic acid 24. Medline “CIRCUMCISION,
bleeding? OR TXA).ti,ab 1942 FEMALE”/ 1304
11. EMBASE "TRANEXAMIC ACID"/ 25. Medline “CIRCUMCISION,
Clinical scenario 12744 MALE”/ 5079
A 4- year-
old boy attended the paedi- 12. EMBASE (10 OR 11) 13151 26. Medline (CIRCUMCIS*).ti,ab 6369
atric emergency department following a 13. EMBASE (post circumcision* 27. Medline (23 OR 24 OR 25 OR 26)
circumcision for religious reasons earlier bleed*).ti,ab 35 8388
that day. He had ongoing bleeding from 14. EMBASE CIRCUMCISION/ 8644 28. Medline (22 AND 27) 6
the surgical site. 15. EMBASE (CIRCUMCIS*).ti,ab 8083
Is there any evidence behind the use of 16. EMBASE (13 OR 14 OR 15) 10281 Search outcome
topical TXA in the management of these 17. EMBASE (12 AND 16) 52 No evidence for the use of topical TXA in
patients? 18. EMBASE 17 [DT 2009-2020] 42 postcircumcision bleeding.
19. Medline (topical tranexamic acid OR
Search strategy TXA).ti,ab 2002
Using databases : CINAHL, EMBASE, Comment
20. Medline “TRANEXAMIC ACID”/ There is no conclusive evidence published
MEDLINE—last 10 years. 3331
(topical tranexamic acid OR T XA).ti,ab about the use of topical TXA in postcir-
21. Medline (tranexamic acid).ti,ab 4189 cumcision bleeding.
(post circumcision* bleed*).ti,ab
22. Medline (19 OR 20 OR 21) 5717
1. CINAHL (topical tranexamic acid Funding The authors have not declared a specific
OR TXA).ti,ab 614 grant for this research from any funding agency in the
public, commercial or not-for-profit sectors.
2. CINAHL "TRANEXAMIC ACID"/
937 Competing interests None declared.
Clinical bottom line
3. CINAHL (tranexamic acid).ti,ab Patient consent for publication Not required.
1547 Provenance and peer review Not commissioned;
There is nothing published to date